Exploring Analyst Views on Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Bay City Observer

Exploring Analyst Views on Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)  Bay City ObserverAfter a recent review, we have noted that shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) have an average target price of $52.7. This is the consensus ...